Alun has more than 28 years of experience in biological mass spectrometry in both academia and industry in the UK, Canada and USA. During this time, he has developed HPLC-mass spectrometry interfaces, methods of analysis for natural products, drug and pesticide analysis, peptide and protein analysis.

Angelika Christ is Facility Manager of the IMB Sequencing Facility, where she leads a team of sequencing and bioinformatition specialists, producing high-quality sequencing libraries and next-generation sequencing data.

Angelika and her team help find researchers the best approach to their sequencing projects — ranging from agriculture, to drug development and medical research — and ensure the best outcomes.

Angelika has 13 years of commercial and research laboratory experience. She has worked in the field of next-generation sequencing since 2010 on various technology platforms and applications.

Angelika holds a Dipl.-Ing (FH) (equivalent to masters degree) in Biochemistry from the Mannheim University of Applied Sciences in Germany and a brings experience in organic chemistry and peptide chemistry as well as cell culture and assay development to her work at the IMB Sequencing Facility.

View Angelika's publications via PubMed

  Cellular reprogramming and ageing group

Highlights

Professor Grant Montgomery uses genetic approaches to discover critical genes and pathways increasing risk for reproductive disorders. He applies state of the art genomic techniques to identify risk factors and understand how these genetic differences regulate gene expression and epigenetics to alter disease risk. The goal is to understand disease biology and help develop better methods for diagnosis and treatment.

A major focus is women’s health and the pathogenesis of endometriosis. Together with colleagues in Brisbane, he led a recent large international study on genetic risk factors for endometriosis which confirmed 14 regions of the genome are associated with the disease, including 5 novel regions. His research is now moving to functional studies to identify the target genes in each region and determine how changes in the regulation of these genes contribute to disease. Professor Montgomery has published the first examples of likely target genes for two regions.

He is also using genomic approaches to help understand environmental risk factors for this disease. Environmental risk factors may leave epigenetic signals on DNA that are associated with disease and he is part of an international study on global methylation analysis in endometriosis.

Video

Connect

Highlights

Associate Professor Irina Vetter has a strong background in neuropharmacology, pain models, toxinology and high-throughput screening. Currently her primary research interests lie in the fields of peripheral pain mechanisms, target identification, biodiscovery of venom peptide ion channel modulators and analgesic drug discovery.

Associate Professor Vetter has always been fascinated by how we perceive the world around us, in particular, the role of sensory neurons in the body. Sensory neurons are an intricate network of nerve cells that convert external stimuli from the environment into messages within the body, like pain. Her research is demystifying the different pathways that contribute to pain in various disease states. She is using biomedical research and pharmacology to develop pain treatments from venoms and toxins.

Associate Professor Vetter is an ARC Future Fellow and Deputy Director of the Centre for Pain Research at The University of Queensland. She is a registered pharmacist and has worked in hospital as well as community pharmacy. She obtained her PhD in 2007 from the School of Pharmacy, and conducted postdoctoral studies as an NHMRC postdoctoral fellow under Prof Geoffrey Goodhill at the Queensland Brain Institute and under Prof Richard J Lewis at the Institute for Molecular Bioscience in the areas of axon guidance and venom peptide pharmacology

Video

Connect